IP Library Granted Patent US 12,508,352
Granted Patent B2
US 12,508,352 · App. 18/147,133 · Granted Dec 30, 2025

Peritoneal dialysis cycler having decreased pH disinfection

Inventors: Markus Nilsson (Lund, SE); Michael Pettersson (Malmo, SE); Oskar Erik Frode Styrbjorn Fallman (Lund, SE); Per-Olof Borgqvist (Lund, SE); Sophie Sandblad (Lund, SE)
Assignees: Baxter International Inc.; Baxter Healthcare SA
A61M1/28A61M1/282A61M1/287A61M1/369A61M2205/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,508,352
App. No.
18/147,133
Granted
Dec 30, 2025
Kind
B2
Abstract

A peritoneal dialysis (“PD”) system includes a plurality of PD fluid components, a reusable PD fluid line selectively fluidly communicating with the PD fluid components, a source of PD fluid selectively fluidly communicating with the reusable PD fluid line, a source of anti-scaling fluid selectively fluidly communicating with the reusable PD fluid line, and a control unit configured to (i) operate the plurality of PD fluid components during treatment using PD fluid from the source heated to a treatment temperature, and (ii) circulate unused PD fluid heated to a disinfection temperature in combination with anti-scaling fluid from the source of anti-scaling fluid after treatment for disinfecting the plurality of PD fluid components and the reusable PD fluid line, the anti-scaling fluid provided in an amount configured to lower the pH of the unused PD fluid to a level below which precipitates are formed and above which the pH causes disinfection.

Claims (34)

1 . A peritoneal dialysis (“PD”) system comprising:

a housing;

a plurality of PD fluid components housed by the housing;

at least one reusable PD fluid line in fluid communication with the plurality of PD fluid components;

a source of PD fluid in valved fluid communication with the at least one reusable PD fluid line;

a source of anti-scaling fluid in valved fluid communication with the at least one reusable PD fluid line;

a control unit configured to (i) cause the plurality of PD fluid components to be operated during treatment using PD fluid from the source of PD fluid, the PD fluid heated to a treatment temperature, and (ii) cause unused PD fluid heated to a disinfection temperature after treatment to be circulated in combination with anti-scaling fluid from the source of anti-scaling fluid for disinfecting the plurality of PD fluid components and the at least one reusable PD fluid line, the anti-scaling fluid provided in an amount configured to lower the pH of the unused PD fluid to a level below which precipitates are formed and at or above a pH of 4; and

a valve and a redundant valve under control of the control unit, the valve and the redundant valve providing the valved fluid communication located between the source of anti-scaling fluid and the at least one reusable PD fluid line.

2 . The PD system of claim 1 , wherein the control unit is configured to cause at least a portion of the anti-scaling fluid to be combined with the unused PD fluid after treatment and prior to heating the unused PD fluid to the disinfection temperature.

3 . The PD system of claim 1 , wherein the control unit is configured to cause at least a portion of the anti-scaling fluid to be combined with the unused PD fluid after treatment and while heating the unused PD fluid to the disinfection temperature.

4 . The PD system of claim 1 , wherein the control unit is configured to cause at least a portion of the anti-scaling fluid to be combined with the unused PD fluid after heating the unused PD fluid to the disinfection temperature.

5 . The PD system of claim 1 , wherein the anti-scaling fluid is an acid.

6 . The PD system of claim 1 , wherein the treatment temperature is about 37° C. and the disinfection temperature is between 70° C. to 95° C.

7 . The PD system of claim 1 , wherein the pH of the unused PD fluid prior to pH lowering is higher than 6.5.

8 . The PD system of claim 1 , wherein the lowered pH level is 6.5 or slightly lower.

9 . The PD system of claim 1 , wherein the plurality of PD fluid components includes a PD fluid pump, the control unit configured to operate the pump to pump the PD fluid and the anti-scaling fluid.

10 . The PD system of claim 1 , wherein the plurality of PD fluid components includes a PD fluid heater, the control unit configured to operate the PD fluid heater to heat the PD fluid to the treatment temperature and the unused PD fluid to the disinfection temperature.

11 . The PD system of claim 1 , wherein the anti-scaling fluid is provided in an amount configured to lower the pHI of the unused PD fluid to a level at a pH between 4 and 6.

12 . A peritoneal dialysis (“PD”) system comprising:

a plurality of PD fluid components;

at least one reusable PD fluid line in fluid communication with the plurality of PD fluid components;

a source of PD fluid in valved fluid communication with the at least one reusable PD fluid line;

a source of anti-scaling fluid in valved fluid communication with the at least one reusable PD fluid line; and

a control unit configured to

(i) cause the plurality of PD fluid components to be operated during treatment using PD fluid from the source of PD fluid, the PD fluid heated to a treatment temperature,

(ii) determine whether unused PD fluid from the source to be used for disinfection includes bicarbonate, and

(iii) when the unused PD fluid from the source to be used for disinfection includes bicarbonate, cause the unused PD fluid heated to a disinfection temperature after treatment to be circulated in combination with anti-scaling fluid from the source of anti-scaling fluid for disinfecting the plurality of PD fluid components and the at least one reusable PD fluid line.

13 . The PD system of claim 12 , wherein (ii) occurs before or after (i).

14 . The PD system of claim 12 , wherein the anti-scaling fluid is provided in an amount configured to lower the pH of the unused PD fluid to a level below which precipitates are formed and above which the pHI causes disinfection.

15 . The PD system of claim 12 , wherein the control unit is configured to cause at least a portion of the anti-scaling fluid to be combined with the unused PD fluid after treatment and prior to heating the unused PD fluid to the disinfection temperature.

16 . The PD system of claim 12 , wherein the control unit is configured to cause at least a portion of the anti-scaling fluid to be combined with the unused PD fluid after treatment and while heating the unused PD fluid to the disinfection temperature.

17 . The PD system of claim 12 , wherein the control unit is configured to cause at least a portion of the anti-scaling fluid to be combined with the unused PD fluid after heating the unused PD fluid to the disinfection temperature.

18 . The PD system of claim 12 , wherein the control unit is further configured, such that when the unused PD fluid from the source to be used for disinfection does not include bicarbonate, the unused PD fluid heated to a disinfection temperature after treatment is circulated without combining the anti-scaling fluid for disinfecting the plurality of PD fluid components and the at least one reusable PD fluid line.

19 . The PD system of claim 12 , wherein determining whether unused PD fluid from the source to be used for disinfection includes including bicarbonate includes determining a type of PD fluid to be used for disinfection.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER HEALTHCARE SA
To: VANTIVE HEALTH GMBH
Reel/Frame 073433/0234 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER INTERNATIONAL INC.
To: VANTIVE US HEALTHCARE LLC
Reel/Frame 074046/0877 →
SECURITY INTEREST Recorded Jan 31, 2025
From: VANTIVE US HEALTHCARE LLC; GAMBRO RENAL PRODUCTS, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 070076/0701 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2023
From: NILSSON, MARKUS; PETTERSSON, MICHAEL; STYRBJORN FALLMAN, OSKAR ERIK FRODE; BORGQUIST, PER-OLOF; SANDBLAD, SOPHIE
To: GAMBRO LUNDIA AB
Reel/Frame 062285/0703 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2023
From: GAMBRO LUNDIA AB
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE SA
Reel/Frame 062285/0732 →